These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1440326)

  • 1. [The determination of apolipoproteins. Its possible diagnostic importance].
    Titov VN; Tvorogova MG
    Ter Arkh; 1992; 64(6):115-9. PubMed ID: 1440326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoprotein(a) as a risk factor for arteriosclerosis].
    Steinmetz A; Utermann G
    Internist (Berl); 1992 Jan; 33(1):24-31. PubMed ID: 1532383
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythrocyte aggregation, erythrocyte filterability and membrane fluidity in single-area atherosclerotic vascular disease].
    Sarno A; Serra A; Catania A; Francavilla G; Lo Presti R; Caimi G
    Ric Clin Lab; 1989; 19 Suppl 1():133-6. PubMed ID: 2629073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis in diabetes].
    Yamada N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():637-41. PubMed ID: 15779453
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effective diagnosis and treatment of atherosclerosis. Canadian Cardiovascular Society.
    Frohlich JJ
    Can J Cardiol; 1995 May; 11 Suppl C():41C-42C. PubMed ID: 7750050
    [No Abstract]   [Full Text] [Related]  

  • 7. Can we measure and predict atherosclerotic progression?
    Furberg CD
    Circulation; 1993 Mar; 87(3 Suppl):II82. PubMed ID: 8443928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Schmidt H; Strauss HJ; Schaedel H; Oswald B
    Z Gesamte Inn Med; 1988 Feb; 43(4):86-92. PubMed ID: 3376506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apolipoproteins as risk factors of atherosclerosis].
    Dargel R; Winkler L
    Z Med Lab Diagn; 1989; 30(1):35-6. PubMed ID: 2718575
    [No Abstract]   [Full Text] [Related]  

  • 10. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of apolipoprotein B determination in evaluation of atherogenic risk].
    Messaoudia Y
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):217-20. PubMed ID: 7181567
    [No Abstract]   [Full Text] [Related]  

  • 13. [Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].
    Parhofer KG
    MMW Fortschr Med; 2001 Jan; 143(4):22-4. PubMed ID: 11219276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apolipoproteins in the evaluation of familial susceptibility to atherosclerosis].
    Jirkovská A; Válek J; Grafnetter D; Vondra K; Skibová J
    Cas Lek Cesk; 1984 Feb; 123(5):130-2. PubMed ID: 6697360
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease.
    Kostner GM; Wurm H; Zechner R; Pilger E; Dieplinger H
    Prog Clin Biol Res; 1985; 188():67-77. PubMed ID: 4059260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arterial occlusive disease as marker illness--interview with Prof. Dr. Curt Diehm. Discover the "silent majority"!].
    Diehm C
    MMW Fortschr Med; 2004; 146 Suppl 1():7. PubMed ID: 15493410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of apolipoproteins in the study of clinical atherosclerosis].
    Valderová J; Válek J; Vondra K; Fabián J; Grajnetter D; Belán A
    Vnitr Lek; 1987 Feb; 33(2):117-22. PubMed ID: 3824935
    [No Abstract]   [Full Text] [Related]  

  • 18. [ Lipids--lipoproteins--apolipoproteins--risk markers in atherosclerosis].
    Slimane MN; Bouslama A; Maatoug F; Hammami M; Ben Farhat MH
    Tunis Med; 1992 Feb; 70(2):91-6. PubMed ID: 1496741
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive versus noninvasive studies of risk factors and atherosclerosis.
    Sharrett AR
    Circulation; 1993 Mar; 87(3 Suppl):II48-53. PubMed ID: 8443923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
    Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
    Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.